Update: UK Biotech Scores £5M Series A to Boost Next-Generation Cancer Antibodies
Update (30/11/2018): IGEM Therapeutics has increased the total raised in Series A to £5M (€5.6M)…
Update (30/11/2018): IGEM Therapeutics has increased the total raised in Series A to £5M (€5.6M)…
Automation is slowly taking over our lives, ranging from smart homes to self-driving cars. With…
Update (13/03/2018): Poxel has started two more Phase III trials in Japan testing its drug…
The emergence of CRISPR/Cas9 technologies has enabled almost unlimited gene editing opportunities. Not only could…
UPDATE (05/09/2017): Innovate UK has granted Themis £3M (€3.3M) to push its Chikungunya Vaccine towards…
Update (26/07/2017): Verona Pharma has dosed the first patients in the PhaseIIb with RPL554 in…
Update (20/07/2017): The European Commision has granted LEO Pharma marketing authorization for Kyntheum (brodalumab), making it…
When the Japanese researcher Shinya Yamanaka managed to reprogram adult cells into an embryonic-like state…
Apart from boasting big players in the space of metabolic diseases including Novo Nordisk and…
Pharmaleads has scored positive results in a first Phase I trial for its DENKI peptide PL265 to treat…
Antoine Papiernik, Managing Partner at the famous European biotech VC Sofinnova, closed Refresh this year…
Carbios has teamed up with TechnipFMC in order to move Carbios' enzymatic recycling process for…